Scott Brun
Directeur/Membre du Conseil chez CABALETTA BIO, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Scott Brun
Sociétés | Poste | Début | Fin |
---|---|---|---|
CABALETTA BIO, INC. | Directeur/Membre du Conseil | 24/06/2021 | - |
Independent Dir/Board Member | 24/06/2021 | - | |
FORTE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/11/2022 | - |
Independent Dir/Board Member | 10/11/2022 | - | |
JASPER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/06/2023 | - |
Independent Dir/Board Member | 20/06/2023 | - | |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 12/02/2020 | - |
Gold Mast Consulting, LLC | President | - | - |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - | - |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Private Equity Investor | - | - |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - | - |
Historique de carrière de Scott Brun
Anciens postes connus de Scott Brun
Sociétés | Poste | Début | Fin |
---|---|---|---|
ABBVIE INC. | Corporate Officer/Principal | - | - |
░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Scott Brun
The Johns Hopkins University School of Medicine | Doctorate Degree |
University of Illinois At Urbana–Champaign | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 13 |
Opérationnelle
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 5 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBVIE INC. | Health Technology |
CABALETTA BIO, INC. | Health Technology |
FORTE BIOSCIENCES, INC. | Health Technology |
JASPER THERAPEUTICS, INC. | Finance |
Entreprise privées | 5 |
---|---|
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Health Technology |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Health Technology |
Gold Mast Consulting, LLC |
- Bourse
- Insiders
- Scott Brun
- Expérience